ArticleDrug design, development and therapy2020

Cost-Effectiveness Analysis of Ezetimibe as the Add-on Treatment to Moderate-Dose Rosuvastatin versus High-Dose Rosuvastatin in the Secondary Prevention of Cardiovascular Diseases in China: A Markov Model Analysis.

Han Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.